“I’m on HRT. Why Don’t I Feel Better?”
I hear versions of this question all the time. A woman finally decides to try hormone replacement therapy because the hot flashes are relentless, she is waking at 3:00 a.m., her brain feels different, her libido has disappeared, her body composition is changing, and she no longer feels quite like herself. She is prescribed estrogen, perhaps progesterone, and increasingly she may also be offered testosterone. She expects to feel better. Sometimes she does. Sometimes she feels partly better. And sometimes, months later, she is still sitting there wondering, “Why don’t I feel like myself?”
The woman considering HRT faces a different version of the same frustration. She has read one article telling her estrogen is the answer and another warning her about hormones. Her friend loves her patch. Someone else swears by testosterone. One practitioner recommends a gel, another recommends a patch, and another has a completely different dosing philosophy. Social media adds another hundred opinions before breakfast. She isn't necessarily afraid of hormone therapy; she simply wants to know which advice applies to her.
This is where women become frustrated, because the experience can begin to feel surprisingly random. Start this. Increase that. Add something else. Wait three months. Change the dose. Perhaps your estrogen is too low. Perhaps your progesterone is too low. Perhaps you need testosterone. The woman becomes the testing ground for the treatment rather than the treatment emerging from a deep understanding of the woman.
I believe women deserve better than that.
I use bioidentical hormone therapy in my practice and believe it can be transformative when it is thoughtfully applied. My concern is not HRT. My concern is what happens when we begin prescribing before we have taken the time to understand the person, her history and the biochemical terrain in which those hormones will operate.
I Want You to Understand Your Body Again
The goal of whole-person hormone care is not to create the “perfect” hormone level. It is not to put every woman on estrogen, progesterone and testosterone, nor is it to keep women away from hormones. The prize is much bigger than that. I want a woman to understand what is happening in her body well enough that the decisions we make together make sense.
I want her to know why she is experiencing the symptoms she is experiencing, what patterns we can identify, what we know about her physiology, what we still need to investigate and why I am recommending a particular treatment. If I prescribe bioidentical estrogen, I want there to be a reason. If I prescribe progesterone, I want there to be a reason. If we consider testosterone, there needs to be a reason. And if I decide that another hormone is not the answer, I want her to understand that reasoning too.
This is also why I continually ask, “What time is it in your body?” There is the time of day, the time of the month and the time of life. A woman in active perimenopause who is still cycling is not hormonally identical to a woman several years beyond her final menstrual period. A woman who had a hysterectomy but retained her ovaries has a different story from a woman whose ovaries were removed. A woman who experienced decades of difficult cycles, PMDD, fibroids, heavy bleeding or significant luteal-phase symptoms brings that history into the menopausal transition. The past does not dictate exactly what will happen next, but it gives us valuable clues.
The prize, ultimately, is not simply symptom reduction. It is helping a woman move into the next phase of her life with clarity, agency and confidence in her own body. In our internal coaching outcomes, women report resolving approximately 85% of the symptoms and concerns they brought to us around perimenopause, menopause and understanding their HRT. That is an internal program outcome rather than a guarantee of an individual medical result, but it reflects something I see repeatedly: when women understand their bodies and we stop treating their symptoms as disconnected events, their experience changes.
The Problem Isn’t HRT. It’s Applying HRT Without Enough Information.
This is where I believe the conversation around hormone therapy needs to mature.
We have increasingly sophisticated ways to prescribe hormones, yet the application can still be surprisingly nonspecific. A woman has hot flashes, so estrogen is prescribed. She doesn't sleep, so progesterone is added. Libido is low, so testosterone enters the picture. When she doesn't feel better, doses are changed. Sometimes that works beautifully. But when it doesn't, simply continuing to adjust hormones without asking deeper questions can become a sophisticated form of guessing.
The problem is not HRT. The problem is the seemingly random application of HRT without enough understanding of the individual woman's biochemical pattern.
Symptoms are the body's outward expression. I want to know what is happening underneath them.
A hot flash is information. Heavy bleeding is information. Insomnia is information. Anxiety is information. Loss of libido is information. Constipation, bloating and changing bowel patterns are information. A lifetime of severe PMS or PMDD is information. Fibroids are information. The fact that a woman felt dramatically different during pregnancy, postpartum or while taking previous hormones is information.
But symptoms alone don't always tell us why the pattern exists.
This is where my approach differs. I want to connect the symptom pattern to the biochemical pattern.
If a woman in her late forties presents with hot flashes but also has extremely heavy bleeding and a history of fibroids, I am not going to reduce her clinical picture to “hot flash equals estrogen.” Her bleeding history matters. Her current cycle matters. Her iron status may matter. Her previous hormonal history matters. What is happening in her gut may matter. Her individual genomic pathways may provide additional information. I want to understand as much of the terrain as is clinically useful before assuming that another dose adjustment is the answer.
This is particularly important for the woman who is already taking HRT and still doesn't feel well. She may assume she hasn't yet reached the “right” estrogen level or that testosterone is the missing ingredient. Sometimes hormone dosing does need adjustment. But sometimes the persistent symptom is telling us to stop looking only at the hormones.
Not every symptom occurring during menopause is caused by menopause. Thyroid dysfunction, iron deficiency, altered glucose regulation, sleep disorders, nutrient deficiencies, gastrointestinal dysfunction, medication effects, chronic stress physiology and other conditions can overlap with the menopausal transition. If we treat every one of those signals by manipulating estrogen, progesterone or testosterone, we risk missing the physiology that is actually asking for our attention.
That is why I don't believe personalized hormone medicine can begin and end with a standard serum hormone panel and a symptom checklist. Those are pieces of information. I want a broader biochemical picture.
NEWS: We Can See More of the Woman Than We Could Before
This is the exciting part of the conversation. We now have tools that can help us investigate aspects of a woman's biology that were once much harder to see, and I use those tools as part of my whole-person approach to perimenopause, menopause and HRT.
One of those tools is DUTCH testing—Dried Urine Test for Comprehensive Hormones. When clinically appropriate, I use DUTCH testing to add information about hormone patterns and metabolites. I am not interested in chasing a “perfect” number or treating a laboratory report. I am looking for biochemical information that may help explain the symptom pattern I am seeing in the person sitting in front of me.
That distinction is essential. DUTCH testing is not the authority. The woman is not a laboratory result. Testing gives me another lens through which to investigate the biology, and I interpret that information alongside her symptoms, medical history, hormonal history, stage of life and the rest of the clinical picture.
I also use GI and microbiome testing because the gut is part of hormone physiology. Estrogens undergo metabolism and elimination involving the gastrointestinal tract, and the collection of microbial genes involved in estrogen metabolism is often referred to as the estrobolome. Research continues to explore the bidirectional relationship between estrogen and the gut microbiome, including microbial enzymes involved in deconjugation and enterohepatic recirculation of estrogens. The science is evolving, and we should be clear that we do not yet have an “ideal menopause microbiome” or a stool-test pattern that tells us exactly how to dose HRT. What we do have is a compelling reason not to pretend that the gut and the hormonal system exist independently of one another.
For a woman with significant bloating, constipation, diarrhea, digestive symptoms or other indications that her gastrointestinal system deserves investigation, I use GI testing to look more deeply. I want to understand the biological environment in which we are asking the rest of her body to function.
The third major layer in my approach is DNA and genomic testing. Your genome does not tell me your destiny, and I never want women frightened by individual genetic variants. What genomic information can do is give us insight into biological pathways and individual variation. Genetics can influence enzymes, receptors, transporters and metabolic processes. When interpreted responsibly and alongside the rest of the clinical picture, genomic information helps me ask more sophisticated questions about why two women with seemingly similar symptoms may not have identical biology.
This is where whole-person medicine becomes truly personalized. The symptom pattern tells me where to look. The biochemical pattern helps me understand what I may be looking at. The woman's history tells me how we arrived here. Together, those pieces help guide what we do next.
DUTCH testing, GI and microbiome testing, and DNA genomic testing are not replacements for clinical judgment. They enhance my ability to investigate. More data are not automatically better medicine. The expertise lies in knowing what to test, why we are testing it, how to interpret it, what its limitations are and how it changes—or does not change—the treatment plan.
At the heart of all of this is still the person.
I don't start with estrogen. I don't start with progesterone. I don't start with testosterone, a DUTCH report, a stool test or a genomic panel. I start with the woman. Then I use the tools available to me to understand her story and her physiology as completely as possible before deciding where bioidentical hormone therapy belongs.
That is the standard I believe women should expect from whole-person hormone care. HRT should not feel like an experiment being performed on you one dose at a time. You should understand why you are taking what you are taking, what we are trying to accomplish, what information informed that decision and how we will determine whether the treatment is actually serving you.
Your menopause did not begin with your first hot flash. Your body arrived here carrying decades of information. Your symptoms have a pattern. Your biochemistry has a pattern. Your history has a pattern.
The work is to understand how those patterns connect.
That is where personalized hormone medicine begins. That’s where you are.
Let’s begin to find you, again.
Mary Louder, DO